Bank of New York Mellon’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-200,304
| Closed | -$114K | – | 4244 |
|
2025
Q1 | $114K | Sell |
200,304
-542
| -0.3% | -$309 | ﹤0.01% | 3965 |
|
2024
Q4 | $287K | Sell |
200,846
-1,198
| -0.6% | -$1.71K | ﹤0.01% | 3782 |
|
2024
Q3 | $390K | Sell |
202,044
-35,553
| -15% | -$68.6K | ﹤0.01% | 3627 |
|
2024
Q2 | $737K | Buy |
237,597
+26,103
| +12% | +$80.9K | ﹤0.01% | 3353 |
|
2024
Q1 | $1.11M | Buy |
211,494
+53
| +0% | +$277 | ﹤0.01% | 3094 |
|
2023
Q4 | $685K | Buy |
211,441
+7,677
| +4% | +$24.9K | ﹤0.01% | 3379 |
|
2023
Q3 | $520K | Buy |
203,764
+2,650
| +1% | +$6.76K | ﹤0.01% | 3521 |
|
2023
Q2 | $1.18M | Buy |
201,114
+73,174
| +57% | +$430K | ﹤0.01% | 3101 |
|
2023
Q1 | $365K | Buy |
127,940
+52,000
| +68% | +$148K | ﹤0.01% | 3653 |
|
2022
Q4 | $153K | Hold |
75,940
| – | – | ﹤0.01% | 4045 |
|
2022
Q3 | $220K | Buy |
75,940
+7,541
| +11% | +$21.8K | ﹤0.01% | 3978 |
|
2022
Q2 | $385K | Sell |
68,399
-4,915
| -7% | -$27.7K | ﹤0.01% | 3747 |
|
2022
Q1 | $864K | Buy |
73,314
+33,726
| +85% | +$397K | ﹤0.01% | 3403 |
|
2021
Q4 | $750K | Buy |
39,588
+5,107
| +15% | +$96.8K | ﹤0.01% | 3554 |
|
2021
Q3 | $712K | Buy |
+34,481
| New | +$712K | ﹤0.01% | 3597 |
|